Role of VAPB-MSP, a Novel EphA2 RTK Antagonist in Breast Cancer

doi 10.21236/ada605663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

A Novel Role for TTK in Homologous Recombination: Implications for Breast Cancer Radiosensitivity

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2020English

A Novel Role of Krüppel-Like Factor 8 in DNA Repair in Breast Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Immunocompetent Mouse Model of Breast Cancer for Preclinical Testing of EphA2-targeted Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2004English

Frequent Epigenetic Inactivation of WNT Antagonist Genes in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2008English

CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2012English

Cks1 Regulates Cdk1 Expression: A Novel Role During Mitotic Entry in Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2007English

C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts With Human VAPB-MSP to Form a Dynamic Replication Complex

PLoS ONE
Multidisciplinary
2016English

119 Breaking Down Barriers: Defining the Role of EphA2 in Building Epidermal Tight Junctions in Cancer

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

A Novel Activating Role of SRC and STAT3 on HGF Transcription in Human Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy